Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anterix Inc. Director's Dealing 2025

Jan 22, 2025

33018_dirs_2025-01-22_0c221123-f3a0-4679-aa7d-8c785ce31f9e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2025-01-17

Reporting Person: Lang Scott A. (Director, President and CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-01-17 Stock Option (Right to Buy) $30.99 A 191326 Acquired 2026-01-17 Common Stock (191326) Direct

Footnotes

F1: The shares subject to the option shall vest and become exercisable in three annual installments with vesting commencing on January 17, 2025, subject to the Reporting Person's continuous services to the Issuer through each such vesting date.